Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Biochemical and pharmacological characterization of different recombinant acid α-glucosidase preparations evaluated for the treatment of Pompe disease

6 Jun 2008

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Child Nutrition and Feeding Issues
Share to Glycogen Storage Diseases and Myoclonus
Share to Lysosomal Storage Disorders Research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 18538603
DOI: 10.1016/j.ymgme.2008.04.009

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Biochemical and pharmacological characterization of different recombinant acid α-glucosidase preparations evaluated for the treatment of Pompe diseasePMID 18538603Read ↗

Advances in Pompe Disease Treatment: From Enzyme Replacement to Gene TherapySemantic proximity Read ↗

Pompe disease: Current state of treatment modalities and animal modelsSemantic proximity Read ↗

N-Octyl-β-valienamine up-regulates activity of F213I mutant β-glucosidase in cultured cells: a potential chemical chaperone therapy for Gaucher diseaseSemantic proximity Read ↗

Pompe Disease: From Basic Science to TherapySemantic proximity Read ↗

Preclinical studies for plant-based oral enzyme replacement therapy (Oral-ERT) in Pompe disease knockout mice with transgenic tobacco seeds expressing human GAA (tobrhGAA)Semantic proximity Read ↗

Pharmacological enhancement of mutated alpha-glucosidase activity in fibroblasts from patients with Pompe disease.Semantic proximity Read ↗

The generation of induced pluripotent stem cells (iPSCs) from patients with infantile and late-onset types of Pompe disease and the effects of treatment with acid-α-glucosidase in Pompe's iPSCsSemantic proximity Read ↗

Characterization of peptides with antioxidant activity and antidiabetic potential obtained from chickpea (Cicer arietinum L.) protein hydrolyzates.Semantic proximity Read ↗

5-C-Branched Deoxynojirimycin: Strategy for Designing a 1-Deoxynojirimycin-Based Pharmacological Chaperone with a Nanomolar Affinity for Pompe Disease.Semantic proximity Read ↗

Protease Inhibitors Purified from the Canola Meal Extracts of Two Genetically Diverse Genotypes Exhibit Antidiabetic and Antihypertension Properties.Semantic proximity Read ↗

Rational Design of Combination Enzyme Therapy for Celiac SprueSemantic proximity Read ↗

Phenolamide-driven α-glucosidase inhibitory activity in immature fruits of the korean landrace-derived chili pepper SumihyangSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.